Albany International Corp (AIN) Stock News

Main Street Capital (MAIN) declined 1.09% to $53.51, underperforming the S&P 500's 0.52% loss. The stock has fallen 1.21% over the past month. Upcoming earnings on November 5, 2026 are expected to show EPS of $1 (up 3.09% YoY) and revenue of $144.47 million (up 3.32% YoY). However, full-year earnings are forecasted to decline 3.8% despite revenue growth of 2.67%. The stock holds a Zacks Rank #3 (Hold) with a Forward P/E of 13.36, trading at a premium to its industry average of 7.28.

Main Street Capital (MAIN) declined 1.34% to $53.74, underperforming the broader market which gained 0.6%. The stock has lost 2.38% over the past month while the Finance sector declined 3.99%. The company is expected to report EPS of $1 (up 3.09% YoY) with revenue projected at $144.47 million (up 3.32% YoY). MAIN holds a Zacks Rank #3 (Hold) rating and trades at a Forward P/E of 13.45, a premium to its industry average of 7.4.

Genmab announced Phase 2 results for Rina-S (rinatabart sesutecan) in platinum-resistant ovarian cancer, demonstrating a 45.9% objective response rate with a median duration of response of 12.1 months and median progression-free survival of 9.5 months. The drug showed antitumor activity regardless of folate receptor alpha expression levels, with manageable tolerability. The company is advancing four Phase 3 trials across multiple gynecologic cancers.

Main Street Capital (MAIN) closed at $55.94, up 1.58% and outperforming the S&P 500's 0.17% decline. The stock has declined 6.53% over the past month. Upcoming earnings are projected at $1 EPS (up 3.09% YoY) with revenue of $144.47 million (up 3.32% YoY). The company holds a Zacks Rank #3 (Hold) with a Forward P/E of 13.6, trading at a premium to its industry average of 7.78.

OneMain Financial, a consumer lending company with 1,400+ branches across 44 states, suffered a data breach in May 2026 that exposed names, addresses, and Social Security numbers of at least 16,988 individuals across multiple states. The breach was disclosed to authorities in September 2026. Edelson Lechtzin LLP is investigating potential class action claims to determine if the company failed to implement adequate cybersecurity safeguards.

Sky Blue Cinematix has been appointed as the exclusive worldwide brand-integration partner for two upcoming feature films from Tested Films: the action thriller 'Habeas Corpus' and the neo-noir romantic mystery 'Blurred', both directed by Ben Cookson. The partnership will connect international brands with these theatrical productions through in-film integration across all territories.

Qualcomm has partnered with HUMAIN to launch the Horizon Ultra AI PC, powered by the Snapdragon X2 Elite platform featuring an 18-core Oryon CPU, Adreno GPU, and Hexagon NPU. The device enables AI workloads to run locally on enterprise PCs while maintaining cloud computing access. Qualcomm competes with NVIDIA and AMD in the growing AI PC market, though its stock has underperformed the industry over the past year.

WisdomTree Multi Asset Issuer has announced an amendment to the Daily Swap Rate for its WisdomTree Silver 3x Daily Leveraged Securities, effective 1 December 2026. The rate will decrease from 0.01248% to 0.00692%, with amendment documents becoming effective on 1 September 2026. BNP Paribas acts as the Swap Provider for this change.

A class action lawsuit has been filed against Erasca, Inc. alleging that the company made false and misleading statements regarding its ERAS-0015 drug candidate. The lawsuit claims the preclinical data was based on improper comparisons and lacked reasonable basis. Following a patent infringement allegation from Revolution Medicines disclosed on April 28, 2026, Erasca's stock price declined approximately 48% from $19.15 to $9.90 per share. Investors have until August 10, 2026 to apply as lead plaintiff.

A class action lawsuit has been filed against Erasca, Inc. alleging the company made false statements about its ERAS-0015 drug candidate based on improper comparisons and lacking reasonable basis. Following a patent infringement allegation from Revolution Medicines disclosed on April 28, 2026, Erasca's stock price plummeted 48% from $19.15 to $9.90 per share. Investors have until August 10, 2026 to apply as lead plaintiff.

Aurion Resources Ltd. has obtained final court approval for its plan of arrangement with Agnico Eagle Mines Limited. Under the deal, Agnico will acquire all outstanding Aurion shares for C$2.60 per share in cash. The arrangement was approved by shareholders and warrantholders on June 5, 2026, and is expected to close on or about June 15, 2026, pending TSX Venture Exchange approval and satisfaction of customary closing conditions.

Aurion Resources Ltd. announced that its securityholders approved a special resolution to be acquired by Agnico Eagle Mines Limited for C$2.60 per share in cash. The arrangement received overwhelming approval with 99.94% of votes cast in favor. The deal is anticipated to close on or about June 15, 2026, pending final court approval and TSX Venture Exchange approval.

RAIN, an Arbitrum-based prediction market protocol, announced $200 million in ecosystem commitments through a partnership with Enlivex and $100 million in liquidity expansion ($50M USDT, $50M RAIN). The protocol is preparing for Version 2 launch featuring permissionless market creation, AMMs, on-chain order books, and AI-assisted market resolution, with plans for major expansion around the FIFA World Cup.

BGIN Blockchain Limited announced the launch of its ASIC Chip Customization Solutions Business and completed its first customer hardware delivery. The new business extends the company's internal ASIC chip design and hardware engineering capabilities to external third-party customers. BGIN delivered 3,000 customized PoW mining machines to a protocol project customer, with 2,400 units delivered directly and 600 units available through the ICERIVER sales channel.

BGIN Blockchain reported a $177 million net loss for 2025 compared to $66.1 million net income in 2024, with total revenue declining 78% to $67.4 million. The company executed a strategic transformation, scaling back its altcoin business to focus on Bitcoin infrastructure, achieving first-pass silicon success on its 4nm BT1 Bitcoin mining chip in March 2026. Despite the losses driven primarily by